Showing 7 of 7 recruiting trials for “Atypical teratoid rhabdoid tumor”
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
👨⚕️ Giselle Saulnier Sholler, MD, Penn State Health Children's Hospital📍 6 sites📅 Started Mar 2026View details ↗
Study to ONO-4538 in Patients With Rhabdoid Tumor
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors
👨⚕️ Christopher DeRenzo, MD, St. Jude Children's Research Hospital📍 1 site📅 Started Apr 2023View details ↗
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →